0001237899-20-000029.txt : 20200708 0001237899-20-000029.hdr.sgml : 20200708 20200708161600 ACCESSION NUMBER: 0001237899-20-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200707 FILED AS OF DATE: 20200708 DATE AS OF CHANGE: 20200708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SING GEORGE L CENTRAL INDEX KEY: 0001225471 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 201018548 MAIL ADDRESS: STREET 1: LANCET CAPITAL STREET 2: 45 ROCKEFELLER PLAZA STE 2008 CITY: NEW YORK STATE: NY ZIP: 10111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-07-07 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001225471 SING GEORGE L 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2020-07-07 4 M 0 7500 33.42 A 122915 D Common Stock 2020-07-07 4 S 0 7500 650.0 D 115415 D Common Stock 2020-07-07 4 S 0 500 650.0 D 1150 I by Spouse Common Stock 2020-07-07 4 S 0 800 650.32 D 600 I by Spouse/Cust Son Common Stock 2020-07-07 4 S 0 200 651.09 D 400 I by Spouse/Cust Son Common Stock 2020-07-07 4 S 0 1500 650.0 D 4700 I by Trust for Son Non-Qualified Stock Option (right to buy) 33.42 2020-07-07 4 M 0 7500 0.0 D 2021-01-03 Common Stock 7500 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 800 shares of Company stock on July 7, 2020 at prices ranging from $650.00 to $650.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 7, 2020 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on July 7, 2020 at prices ranging from $651.02 to $651.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 7, 2020 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**George L. Sing 2020-07-07